Acute Cycling on Executive Control

NCT ID: NCT03499977

Last Updated: 2024-05-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-07-01

Study Completion Date

2019-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will examine whether 10-minute bouts of cycling at various intensities will impact executive functioning (i.e., cognitive ability) as assessed by the antisaccade (AS) task through a total of five visits. An antisaccade is a rapid eye movement away from a visual target. The ability to suppress making an eye movement towards a visual target gauges inhibitory control (i.e., a domain of executive functioning). In the initial visit, participants' exercise capacity will be assessed through a maximal effort cycling test. Intensities for the cycling bouts (i.e., high, moderate, low) in subsequent sessions will be based upon this maximal effort cycling test. In visits 2 through 5, participants will complete an AS task, followed by a 10-minute bout of cycling, and then complete the AS task again. The order of cycling intensities will be randomized between participants. Differences in the AS task (i.e., reaction time and accuracy) will be compared between and within cycling conditions.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Physical Activity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Sitting

The participant will be asked to sit for 10 min (not increasing their heart rate) then do the anti-saccade task

Group Type EXPERIMENTAL

Sitting

Intervention Type BEHAVIORAL

10 min bouts

Low-Intensity Cycling

Participant will be asked to cycle for 10 min (\<40% VO2R) and then perform the anti-saccade task

Group Type EXPERIMENTAL

Light-Intensity Cycling

Intervention Type BEHAVIORAL

10min bout

Moderate-Intensity Cycling

The participant will be asked to do 10 min of cycling (40-59% VO2R) followed but the anti-saccade task

Group Type EXPERIMENTAL

Moderate-Intensity Cycling

Intervention Type BEHAVIORAL

10 min bout

High-Intensity Cycling

The participant will be asked to do 10 min of cycling (60%-84% VO2R) followed but the anti-saccade task

Group Type EXPERIMENTAL

High-Intensity Cycling

Intervention Type BEHAVIORAL

10 min bout

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Sitting

10 min bouts

Intervention Type BEHAVIORAL

Light-Intensity Cycling

10min bout

Intervention Type BEHAVIORAL

Moderate-Intensity Cycling

10 min bout

Intervention Type BEHAVIORAL

High-Intensity Cycling

10 min bout

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Able to read, write and understand English
* Full time student enrolled at Western University
* Able to perform a ten-minute exercise task at a light intensity without health implications
* Have email or phone number for contacting purposes

Exclusion Criteria

* Do not have a medical condition that prevents you from exercise (e.g. heart attack in the past year, heart disease, irregular heartbeat, etc.)
* Do not have history of eye injury or neurological impairment
* Do not have an orthopaedic limitation
* Are not pregnant
Minimum Eligible Age

18 Years

Maximum Eligible Age

64 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Western University, Canada

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Dr. Harry Prapavessis

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Harry Prapavessis, Ph.D

Role: PRINCIPAL_INVESTIGATOR

Western University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Western University

London, Ontario, Canada

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Canada

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PA and Executive Functioning

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.